Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical utility of neuroprotective agents in neurodegenerative diseases: current status of drug development for Alzheimer's, Parkinson's and Huntington's diseases, and amyotrophic lateral sclerosis
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 21, Issue 9, Pages 1267-1308
Publisher
Informa Healthcare
Online
2012-06-28
DOI
10.1517/13543784.2012.703178
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The γ-Secretase Modulator CHF5074 Restores Memory and Hippocampal Synaptic Plasticity in Plaque-Free Tg2576 Mice
- (2018) Claudia Balducci et al. JOURNAL OF ALZHEIMERS DISEASE
- Stimulating Nicotinic Receptors Trigger Multiple Pathways Attenuating Cytotoxicity in Models of Alzheimer's and Parkinson's Diseases
- (2018) Jun Kawamata et al. JOURNAL OF ALZHEIMERS DISEASE
- Effects of AZD3480 on Cognition in Patients with Mild-to-Moderate Alzheimer's Disease: A Phase IIb Dose-Finding Study
- (2018) Lutz Frölich et al. JOURNAL OF ALZHEIMERS DISEASE
- Why Do So Many Drugs for Alzheimer's Disease Fail in Development? Time for New Methods and New Practices?
- (2017) Robert E. Becker et al. JOURNAL OF ALZHEIMERS DISEASE
- CHF5074, a Novel γ-Secretase Modulator, Restores Hippocampal Neurogenesis Potential and Reverses Contextual Memory Deficit in a Transgenic Mouse Model of Alzheimer's Disease
- (2017) Bruno P. Imbimbo et al. JOURNAL OF ALZHEIMERS DISEASE
- Acute Effect on the Aβ Isoform Pattern in CSF in Response to γ-Secretase Modulator and Inhibitor Treatment in Dogs
- (2017) Erik Portelius et al. JOURNAL OF ALZHEIMERS DISEASE
- PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
- (2017) Noel G. Faux et al. JOURNAL OF ALZHEIMERS DISEASE
- Propargylamine Containing Compounds as Modulators of Proteolytic Cleavage of Amyloid Protein Precursor: Involvement of MAPK and PKC Activation
- (2017) Orit Bar-Am et al. JOURNAL OF ALZHEIMERS DISEASE
- M30, a brain permeable multi target neurorestorative drug in post nigrostriatal dopamine neuron lesion of parkinsonism animal models
- (2015) Moussa B.H. Youdim PARKINSONISM & RELATED DISORDERS
- Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency
- (2012) Kambiz N. Alavian et al. BRAIN RESEARCH
- Are Anti-Angiogenic Drugs Useful in Neurodegenerative Disorders?
- (2012) Daniele De Filippis et al. CNS & Neurological Disorders-Drug Targets
- EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
- (2012) B. Vellas et al. Current Alzheimer Research
- Targeting Monoamine Oxidases with Multipotent Ligands: An Emerging Strategy in the Search of New Drugs Against Neurodegenerative Diseases
- (2012) L. Pisani et al. CURRENT MEDICINAL CHEMISTRY
- Structural Determinants of the Multifunctional Profile of Dual Binding Site Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents
- (2012) Carles Galdeano et al. CURRENT PHARMACEUTICAL DESIGN
- Differential Effects between -Secretase Inhibitors and Modulators on Cognitive Function in Amyloid Precursor Protein-Transgenic and Nontransgenic Mice
- (2012) Y. Mitani et al. JOURNAL OF NEUROSCIENCE
- Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model
- (2012) C. Sunyach et al. NEUROPHARMACOLOGY
- ACS Chemical Neuroscience Molecule Spotlight on ELND006: Another γ-Secretase Inhibitor Fails in the Clinic
- (2011) Corey R. Hopkins ACS Chemical Neuroscience
- PPAR gamma/RXR induced and CD36-mediated Abeta phagocytosis results in cognitive improvement in APP/PS1 mice
- (2011) Mitsugu Yamanaka et al. Alzheimers & Dementia
- Identification of Exebryl-1® and other novel small molecules as tau protein aggregation inhibitors
- (2011) Qubai Hu et al. Alzheimers & Dementia
- The gamma-secretase inhibitor BMS-708163 causes dose-dependent reductions in CSF Aβ40 levels in patients with mild-to-moderate Alzheimer's disease (AD)
- (2011) Charles Albright et al. Alzheimers & Dementia
- Relationship Between Late-Life Hypertension, Blood Pressure, and Alzheimer’s Disease
- (2011) Yuan-Han Yang et al. American Journal of Alzheimers Disease and Other Dementias
- ST101 induces a novel 17kDa APP cleavage that precludes Aβ generation in vivo
- (2011) Kim N. Green et al. ANNALS OF NEUROLOGY
- Tramiprosate in mild-to-moderate Alzheimer’s disease – a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)
- (2011) Paul S. Aisen et al. Archives of Medical Science
- T-817MA, a neuroprotective agent, attenuates the motor and cognitive impairments associated with neuronal degeneration in P301L tau transgenic mice
- (2011) Tetsuo Fukushima et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease
- (2011) Tanya L. Wallace et al. BIOCHEMICAL PHARMACOLOGY
- Alzheimer's disease & metals: therapeutic opportunities
- (2011) Vijaya B Kenche et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Step Further Towards Multitarget Drugs for Alzheimer and Neuronal Vascular Diseases: Targeting the Cholinergic System, Amyloid-β Aggregation and Ca2++ Dyshomeostasis
- (2011) R. Leon et al. CURRENT MEDICINAL CHEMISTRY
- Multi-Target-Directed Ligands in Alzheimer's Disease Treatment
- (2011) M. Bajda et al. CURRENT MEDICINAL CHEMISTRY
- Interacting with γSecretase for Treating Alzheimer's Disease: From Inhibition to Modulation
- (2011) F. Panza et al. CURRENT MEDICINAL CHEMISTRY
- NAP (Davunetide) Provides Functional and Structural Neuroprotection
- (2011) Illana Gozes CURRENT PHARMACEUTICAL DESIGN
- Hybrid-Based Multi-Target Ligands for the Treatment of Alzheimer's Disease
- (2011) Angela Rampa et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- The preclinical discovery of amyotrophic lateral sclerosis drugs
- (2011) Marcie A Glicksman Expert Opinion on Drug Discovery
- Novel therapy in Parkinson's disease: adenosine A2Areceptor antagonists
- (2011) Nikoletta Szabó et al. Expert Opinion on Drug Metabolism & Toxicology
- Emerging drugs for amyotrophic lateral sclerosis
- (2011) Ali Aamer Habib et al. EXPERT OPINION ON EMERGING DRUGS
- Several down, a few to go: histamine H3 receptor ligands making the final push towards the market?
- (2011) Sebastiaan Kuhne et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Istradefylline for the treatment of Parkinson's disease
- (2011) Ariane Park et al. EXPERT OPINION ON PHARMACOTHERAPY
- Novel γ-secretase modulators: a review of patents from 2008 to 2010
- (2011) Martin Pettersson et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The alpha-synuclein 5′untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
- (2011) Jack T. Rogers et al. JOURNAL OF NEURAL TRANSMISSION
- Developing β-secretase inhibitors for treatment of Alzheimer’s disease
- (2011) Arun K. Ghosh et al. JOURNAL OF NEUROCHEMISTRY
- The Alzheimer’s therapeutic PBT2 promotes amyloid-β degradation and GSK3 phosphorylation via a metal chaperone activity
- (2011) Peter J. Crouch et al. JOURNAL OF NEUROCHEMISTRY
- Phosphodiesterase-4D Knock-Out and RNA Interference-Mediated Knock-Down Enhance Memory and Increase Hippocampal Neurogenesis via Increased cAMP Signaling
- (2011) Y.-F. Li et al. JOURNAL OF NEUROSCIENCE
- Selective Hippocampal Neurodegeneration in Transgenic Mice Expressing Small Amounts of Truncated A Is Induced by Pyroglutamate-A Formation
- (2011) A. Alexandru et al. JOURNAL OF NEUROSCIENCE
- Altered tryptophan metabolism in Parkinson's disease: A possible novel therapeutic approach
- (2011) Nikoletta Szabó et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial
- (2011) Robert A Hauser et al. LANCET NEUROLOGY
- Unknown
- (2011) Daniel Paris et al. MOLECULAR MEDICINE
- Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double-blind trials
- (2011) Cristina Sampaio et al. MOVEMENT DISORDERS
- The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosis
- (2011) Merit Cudkowicz et al. NATURE MEDICINE
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
- (2011) Mali Jiang et al. NATURE MEDICINE
- Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway
- (2011) Hyunkyung Jeong et al. NATURE MEDICINE
- Priorities in Parkinson's disease research
- (2011) Wassilios G. Meissner et al. NATURE REVIEWS DRUG DISCOVERY
- “Lest we forget you — methylene blue …”
- (2011) R. Heiner Schirmer et al. NEUROBIOLOGY OF AGING
- Mice Lacking Major Brain Gangliosides Develop Parkinsonism
- (2011) Gusheng Wu et al. NEUROCHEMICAL RESEARCH
- A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
- (2011) S. Salloway et al. NEUROLOGY
- Review: The role of mitochondria in the pathogenesis of amyotrophic lateral sclerosis
- (2011) L. M. Duffy et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- 5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
- (2011) Fei Shen et al. NEUROPHARMACOLOGY
- EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors
- (2011) Jos Prickaerts et al. NEUROPHARMACOLOGY
- Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
- (2011) Marie Therese Armentero et al. PHARMACOLOGY & THERAPEUTICS
- Pharmacotherapies for Alzheimer's disease: Beyond cholinesterase inhibitors
- (2011) Haythum O. Tayeb et al. PHARMACOLOGY & THERAPEUTICS
- Sodium/myo-Inositol Transporters: Substrate Transport Requirements and Regional Brain Expression in the TgCRND8 Mouse Model of Amyloid Pathology
- (2011) Daniela Fenili et al. PLoS One
- The emergence of designed multiple ligands for neurodegenerative disorders
- (2011) Werner J. Geldenhuys et al. PROGRESS IN NEUROBIOLOGY
- The future of Alzheimer's disease: The next 10 years
- (2011) Harald Hampel et al. PROGRESS IN NEUROBIOLOGY
- Treating brain tumors with PDE4 inhibitors
- (2011) Rajarshi Sengupta et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy
- (2010) Hailin Zheng et al. ACS Chemical Biology
- PF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease
- (2010) Marwan N. Sabbagh et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Nic5-15: a novel natural gamma-secretase inhibitor that attenuates brain beta-amyloid content and improves cognition
- (2010) Giulio Pasinetti et al. Alzheimers & Dementia
- Evp-6124: Safety, Tolerability And Cognitive Effects Of A Novel A7 Nicotinic Receptor Agonist In Alzheimer'S Disease Patients On Stable Donepezil Or Rivastigmine Therapy
- (2010) Dana Hilt et al. Alzheimers & Dementia
- APP-selective gamma secretase inhibitor ELND006 effects on brain parenchymal and vascular amyloid beta in the PDAPP mouse model of Alzheimer's disease
- (2010) Sally Schroeter et al. Alzheimers & Dementia
- E2012, a novel gamma-secretase modulator, decreases plasma amyloid-beta (Aβ) levels in humans
- (2010) Christa Nagy et al. Alzheimers & Dementia
- Real-time Microdialysis for aβ Inhibition And Pk/pd Analysis in A Nonhuman Primate Model: In Vivo Efficacy of a Bace-1 Inhibitor
- (2010) Jeremy Yu et al. Alzheimers & Dementia
- Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities
- (2010) Ines Batinic-Haberle et al. AMINO ACIDS
- The cholinergic system in aging and neuronal degeneration
- (2010) Reinhard Schliebs et al. BEHAVIOURAL BRAIN RESEARCH
- Recent developments in adenosine receptor ligands and their potential as novel drugs
- (2010) Christa E. Müller et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
- Discovery of MK-0952, a selective PDE4 inhibitor for the treatment of long-term memory loss and mild cognitive impairment
- (2010) Michel Gallant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice
- (2010) Ji-Seon Seo et al. BRAIN RESEARCH
- Combined Therapy with Idebenone and Deferiprone in Patients with Friedreich’s Ataxia
- (2010) Daniel Velasco-Sánchez et al. CEREBELLUM
- An Open-Label, Positron Emission Tomography Study to Assess Adenosine A2A Brain Receptor Occupancy of Vipadenant (BIIB014) at Steady-State Levels in Healthy Male Volunteers
- (2010) David J. Brooks et al. CLINICAL NEUROPHARMACOLOGY
- Pharmacological Therapy in Parkinson's Disease: Focus on Neuroprotection
- (2010) Zsigmond Tamas Kincses et al. CNS Neuroscience & Therapeutics
- Heparin/heparan sulphate-based drugs
- (2010) Neha S. Gandhi et al. DRUG DISCOVERY TODAY
- Etazolate improves performance in a foraging and homing task in aged rats
- (2010) Jason Drott et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharma–nutrition interface: The gap is narrowing
- (2010) Niki A. Georgiou et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- An in vivo pharmacological evaluation of pardoprunox (SLV308) — A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's disease
- (2010) C.A. Jones et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Oral Administration of a GSK3 Inhibitor Increases Brain Insulin-like Growth Factor I Levels
- (2010) Marta Bolós et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- γ-Secretase Modulators as Potential Disease Modifying Anti-Alzheimer’s Drugs
- (2010) Daniel Oehlrich et al. JOURNAL OF MEDICINAL CHEMISTRY
- The γ-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer’s Disease
- (2010) Annamaria Lanzillotta et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Clinically available iron chelators induce neuroprotection in the 6-OHDA model of Parkinson’s disease after peripheral administration
- (2010) David T. Dexter et al. JOURNAL OF NEURAL TRANSMISSION
- Alpha-secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential
- (2010) Stefan F. Lichtenthaler JOURNAL OF NEUROCHEMISTRY
- The relevance of iron in the pathogenesis of Parkinson’s disease
- (2010) Jeswinder Sian-Hülsmann et al. JOURNAL OF NEUROCHEMISTRY
- Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
- (2010) K. J. Black et al. JOURNAL OF NEUROSCIENCE
- Acute -Secretase Inhibition of Nonhuman Primate CNS Shifts Amyloid Precursor Protein (APP) Metabolism from Amyloid- Production to Alternative APP Fragments without Amyloid- Rebound
- (2010) J. J. Cook et al. JOURNAL OF NEUROSCIENCE
- Discovery of Histamine H3 Antagonists for the Treatment of Cognitive Disorders and Alzheimer's Disease
- (2010) J. D. Brioni et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- RG3487, a Novel Nicotinic 7 Receptor Partial Agonist, Improves Cognition and Sensorimotor Gating in Rodents
- (2010) T. L. Wallace et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
- (2010) Vanessa Villard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- GM1 ganglioside in Parkinson's disease: Results of a five year open study
- (2010) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A pilot trial of the microtubule-interacting peptide (NAP) in mice overexpressing alpha-synuclein shows improvement in motor function and reduction of alpha-synuclein inclusions
- (2010) Sheila M. Fleming et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Bringing natural products into the fold – exploring the therapeutic lead potential of secondary metabolites for the treatment of protein-misfolding-related neurodegenerative diseases
- (2010) P. Matthew Joyner et al. NATURAL PRODUCT REPORTS
- Natural products as a source of Alzheimer's drug leads
- (2010) Philip Williams et al. NATURAL PRODUCT REPORTS
- Alzheimer's disease: strategies for disease modification
- (2010) Martin Citron NATURE REVIEWS DRUG DISCOVERY
- Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release
- (2010) Kranthi Kumari Naga et al. NEUROMOLECULAR MEDICINE
- HDAC inhibitors and neurodegeneration: At the edge between protection and damage
- (2010) Karen C. Dietz et al. PHARMACOLOGICAL RESEARCH
- Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases
- (2010) C. Gibrat et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats
- (2010) Yu-Fang Cheng et al. PSYCHOPHARMACOLOGY
- The sigma-1 receptor chaperone as an inter-organelle signaling modulator
- (2010) Tsung-Ping Su et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor
- (2010) Kevin W. Gillman et al. ACS Medicinal Chemistry Letters
- Exebryl-1: A novel small molecule currently in human clinical trials as a disease-modifying drug for the treatment of Alzheimer's disease
- (2009) Alan D. Snow et al. Alzheimers & Dementia
- In vivo efficacy of BACE-1 inhibitor CTS21166 (ASP1702) in rat CNS compartments
- (2009) Jeremy Yu et al. Alzheimers & Dementia
- R3487/MEM 3454, a novel nicotinic alpha 7 receptor partial agonist, improves attention and working memory performance in cynomolgus macaques
- (2009) T.L. Wallace et al. BIOCHEMICAL PHARMACOLOGY
- TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia
- (2009) T.A. Hauser et al. BIOCHEMICAL PHARMACOLOGY
- Sirtuins inhibitors: The approach to affinity and selectivity
- (2009) Yana Cen BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Heat shock protein 90: translation from cancer to Alzheimer's disease treatment?
- (2009) Wenjie Luo et al. BMC NEUROSCIENCE
- The Role of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) in Alzheimer’s Disease
- (2009) Qingguang Jiang et al. CNS DRUGS
- Designing Multiple Ligands – Medicinal Chemistry Strategies and Challenges
- (2009) Richard Morphy et al. CURRENT PHARMACEUTICAL DESIGN
- Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitors
- (2009) Albert Fournier et al. Expert Review of Neurotherapeutics
- Inhibitors for Human Glutaminyl Cyclase by Structure Based Design and Bioisosteric Replacement
- (2009) Mirko Buchholz et al. JOURNAL OF MEDICINAL CHEMISTRY
- The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal
- (2009) John Hardy JOURNAL OF NEUROCHEMISTRY
- Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein -Secretase for the Treatment of Alzheimer's Disease
- (2009) R. L. Martone et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
- (2009) R. A. Hodgson et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease
- (2009) Velandai Srikanth et al. NEUROBIOLOGY OF AGING
- NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
- (2009) Natalia Shiryaev et al. NEUROBIOLOGY OF DISEASE
- Molecular and clinical pathways to neuroprotection of dopaminergic drugs in Parkinson disease
- (2009) A. H.V. Schapira NEUROLOGY
- Adenosine, adenosine A2A antagonists, and Parkinson's disease
- (2009) P. Jenner et al. PARKINSONISM & RELATED DISORDERS
- The pharmacology of sigma-1 receptors
- (2009) Tangui Maurice et al. PHARMACOLOGY & THERAPEUTICS
- Multiple roles of HDAC inhibition in neurodegenerative conditions
- (2009) De-Maw Chuang et al. TRENDS IN NEUROSCIENCES
- Discovery and development of heat shock protein 90 inhibitors
- (2008) Tony Taldone et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The histamine H3receptor: an attractive target for the treatment of cognitive disorders
- (2008) T A Esbenshade et al. BRITISH JOURNAL OF PHARMACOLOGY
- KNS-760704 [(6R)-4,5,6,7-tetrahydro-N6-propyl-2, 6-benzothiazole-diamine dihydrochloride monohydrate] for the Treatment of Amyotrophic Lateral Sclerosis
- (2008) Valentin K. Gribkoff et al. CNS Neuroscience & Therapeutics
- Treatment with edaravone, initiated at symptom onset, slows motor decline and decreases SOD1 deposition in ALS mice
- (2008) Hidefumi Ito et al. EXPERIMENTAL NEUROLOGY
- PYM50028, a novel, orally active, nonpeptide neurotrophic factor inducer, prevents and reverses neuronal damage induced by MPP+ in mesencephalic neurons and by MPTP in a mouse model of Parkinson’s disease
- (2008) Naomi P. Visanji et al. FASEB JOURNAL
- Role of glial cell derived neurotrophic factor in the protective effect of smilagenin on rat mesencephalic dopaminergic neurons damaged by MPP+
- (2008) Yongfang Zhang et al. FEBS LETTERS
- The neuroprotective mechanism of action of the multimodal drug ladostigil
- (2008) Orly Weinreb Frontiers in Bioscience-Landmark
- Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington’s disease
- (2008) Judit Pallos et al. HUMAN MOLECULAR GENETICS
- Multi-target-Directed Ligands To Combat Neurodegenerative Diseases
- (2008) Andrea Cavalli et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells
- (2008) Francisco Molina-Holgado et al. JOURNAL OF NEUROCHEMISTRY
- Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS
- (2008) Bernadett Kalmar et al. JOURNAL OF NEUROCHEMISTRY
- The Chaperone Activity of Heat Shock Protein 90 Is Critical for Maintaining the Stability of Leucine-Rich Repeat Kinase 2
- (2008) L. Wang et al. JOURNAL OF NEUROSCIENCE
- From Dual Binding Site Acetylcholinesterase Inhibitors to Multi-Target-Directed Ligands (MTDLs): A Step Forward in the Treatment of Alzheimers Disease
- (2008) Maria Bolognesi et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Arimoclomol at dosages up to 300 mg/day is well tolerated and safe in amyotrophic lateral sclerosis
- (2008) Merit E. Cudkowicz et al. MUSCLE & NERVE
- Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease–like pathology
- (2008) Stephan Schilling et al. NATURE MEDICINE
- Sirtuins — novel therapeutic targets to treat age-associated diseases
- (2008) Siva Lavu et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of M1-receptor mRNA stability by smilagenin and its significance in improving memory of aged rats
- (2008) Yaer Hu et al. NEUROBIOLOGY OF AGING
- A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice
- (2008) Toshiyuki Kawasaki et al. NEUROPHARMACOLOGY
- Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression
- (2008) J.C. Lauterborn et al. NEUROSCIENCE
- Neuroprotection for Huntington’s disease: Ready, set, slow
- (2008) Steven M. Hersch et al. Neurotherapeutics
- Memoquin: A multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer’s disease
- (2008) Maria Laura Bolognesi et al. Neurotherapeutics
- Dual-target-directed drugs that block monoamine oxidase B and adenosine A2A receptors for Parkinson’s disease
- (2008) Jacobus P. Petzer et al. Neurotherapeutics
- Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid beta-induced impairment of recognition memory in mice
- (2007) Tursun Alkam et al. BEHAVIOURAL BRAIN RESEARCH
- Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV
- (2007) Lichuan Yang et al. EXPERIMENTAL NEUROLOGY
- Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factor-α in an animal model of inflamed Alzheimer’s disease brain
- (2007) Jae K. Ryu et al. NEUROBIOLOGY OF DISEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now